The aim of this report was to study the effect of sildena®l, a speci®c type-5 phosphodiesterase inhibitor, on human sperm motility, viability, membrane integrity and sperm penetration assay.Spermatozoa were obtained from normal donors (n 6) and infertile men (n 6) were washed using a single Percoll (80%) gradient, suspended in Ham's F-10 medium, and incubated with various doses of sildena®l (125, 250 and 750 ngaml); pentoxifylline (3 mM) was used as a positive control, and Ham's F-10 was used as a reagent control. Sperm motility, grade, viability, membrane integrity (by hypo-osmotic swelling test), and motion evaluation were carried out at various time intervals. Hamster ova sperm penetration assay (SPA) was used to evaluate overall sperm function.Sildena®l did not affect sperm motility, viability or membrane integrity under these conditions as compared to our Ham's control (P b 0.05). Incubation with pentoxifylline signi®cantly enhanced sperm motility (P`0.05) and viability without affecting membrane integrity (P`0.05). Sperm incubated with sildena®l and pentoxifylline from both normal donors and infertile patients demonstrated no signi®cant change in sperm penetration assay from respective controls.In conclusion, sildena®l, at the doses evaluated, did not signi®cantly alter the motility, viability, membrane integrity or sperm penetration characteristics of human spermatozoa from normal donors and infertile patients.